据安迅思新闻(ICIS News)新加坡9月5日消息,日本旭化成周二表示,公司已经与中国蓝星(集团)有限公司签署合资企业协议,将在中国生产和销售改性聚苯醚(mPPE)。
两家公司的目标是生产3万吨/年的聚合物PPE和2万吨/年的mPPE。
该协议的财务细节没有对外透露。
旭化成表示:“双方当前将开始研究新建2,6-二甲苯酚、PPE和mPPE生产设施,并推进合资业务详细的经济性评价,目标是在2018年3月前作出最终投资决定。“
旭化成和中国蓝星(集团)有限公司创建了两家合资企业,分别负责在华的mPPE业务的生产和销售。
张春晓 摘译自 安迅思新闻
原文如下:
Asahi Kasei, Bluestar form joint ventures for China mPPE business
Asahi Kasei has entered into a joint venture deal with China National Bluestar (Group) Co Ltd to produce and sell modified polyphenylene ether (mPPE) in China, the Japanese producer said on Tuesday.
The companies aim to produce 30,000 tonnes/year of polymer PPE (polyphenylene ether) and 20,000 tonnes/year mPPE.
Financial details of the deal were not disclosed.
“Asahi Kasei and Bluestar will now begin studying the construction of manufacturing facilities for 2,6-xylenol, PPE, and mPPE, and proceed with detailed evaluation of the economics of the joint business targeting a final investment decision by March 2018,” Asahi Kasei said.
Asahi Kasei and Bluestar created two joint venture firms to separately handle the manufacturing and sales of mPPE operations in China.